跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gabasaph-300 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Gabasaph-300
Approved
STANDARD
Gabasaph-300
Sapphire Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5ad69a9bfb22c750
Company
Sapphire Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
5ad69a9bfb22c750
Drug Approval Philippines Name
Gabasaph-300
Product Name
Gabasaph-300
Registration Number
DRP-11788
Brand Name
Gabasaph-300
Generic Name
Gabapentin
Dosage Form
Capsule
Dosage Strength
300 mg
Manufacturer
Sapphire Lifesciences Pvt. Ltd.
Importer
Ollen Pharma Trading, Inc.
Distributor
Ollen Pharma Trading, Inc.
Issuance Date
29 April 2022
Expiry Date
29 April 2027
Pharmacologic Category
Antiepileptic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5ad69a9bfb22c750
Type
Standard
Back to Philippines FDA Approvals